Table 5.

PSAS Total Scores (Mean ± SD) for 14 Patients Who Did Not Complete 42 Days of Post-Placebo Phase (Analysis 3). Comparison with 103 Patients Who Completed 42 Post-Placebo Days (Data in Table 3)

	Baseline	Placebo	Post-placebo day
			3	7	14	21	28	35
n	14	14	12	11	11	7	2	2
Mean	22.11	35.85a	29.58	29.27b	26.54	28.00	32.0	20.0
SD	13.00	14.92	13.13	11.85	13.49	18.07	8.49	14.14
Mean Differencec	−1.43	−2.45	−2.84	−1.46	−4.68	−4.30	4.04	−9.89
95% CIc	−8.30 5.46	−11.32 6.42	−13.48 7.80	−12.50 9.56	−16.56 7.21	−19.41 10.80	−19.90 27.98	−34.8 15.0
t = c	0.41	−0.55	−0.53	−0.26	−0.78	−0.57	0.34	−0.79
p = c	0.68	0.59	0.60	0.79	0.44	0.57	0.74	0.43

Within subject comparison by paired t tests against baseline

^ap ≤.0005;

^bp ≤.005.

^cBetween subject (completers [Table 3] vs. noncompleters [this table]) comparison with independent t tests.